We are live on ! Find out more
AEMD icon

Aethlon Medical

9 hedge funds and large institutions have $1.88M invested in Aethlon Medical in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more funds holding

Funds holding: 79 (+2)

0% more ownership

Funds ownership: 0%0% (+0%)

17% less capital invested

Capital invested by funds: $2.26M → $1.88M (-$383K)

Holders
9
Holders Change
+2
Holders Change %
+28.57%
% of All Funds
0.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

AEMD Hedge Fund Activity: Q4 2016 in Review

9 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q4 2016, worth a combined $1.88M — down 17% from $2.26M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new AEMD positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Creative Planning, opening a new position worth an estimated $56K. The largest seller was Royal Bank of Canada, cutting an estimated $3K.

  • 9 institutional investors held Aethlon Medical (AEMD) as of Q4 2016, up from 7 in Q3 2016.
  • Funds reported $1.88M of Aethlon Medical stock for Q4 2016, down 17% quarter-over-quarter.
  • 2 funds opened new Aethlon Medical positions in Q4 2016 and 0 closed out, a net change of +2 holders.
  • The largest Aethlon Medical buyer in Q4 2016 was Creative Planning, an estimated $56K added.
  • The largest Aethlon Medical seller in Q4 2016 was Royal Bank of Canada, an estimated $3K sold.

Based on aggregated 13F filings for Q4 2016.